Modern Pharmaceuticals: Sinopharm Zhijun, the holding subsidiary, obtained the drug registration certificate of Cefotaxime Tablets. Modern Pharmaceuticals announced that Sinopharm Zhijun Pharmaceutical Co., Ltd., the holding subsidiary, recently received the Drug Registration Certificate of Cefotaxime Tablets approved and issued by National Medical Products Administration. Cefopoxime axetil tablets are the third generation cephalosporins taken orally, which are used to treat upper respiratory tract infections and lower respiratory tract infections caused by sensitive bacteria. In 2023, the global sales of preparations will be USD 370 million, and the sales of public hospitals nationwide will be RMB 102 million. The accumulative R&D investment of Sinopharm Zhijun is about RMB 28.45 million. Obtaining the registration certificate will enrich the company's product line, increase market competitiveness and have a positive impact on the company's future development. However, drug sales are easily affected by factors such as policies and market environment, and there are uncertainties.European stocks opened lower, European Stoxx 50 index fell 0.15%, European stocks opened lower, European Stoxx 50 index fell 0.15%, German DAX index fell 0.03%, British FTSE 100 index fell 0.3%, and French CAC40 index fell 0.3%.The wide currency and weak credit logic may continue, and the upward direction of the market volatility will not change. The Shanghai and Shenzhen 300ETF South (159925) is gaining momentum. On December 11, the Shanghai and Shenzhen 300ETF South (159925) closed down by 0.25%, with a turnover of 75,892,100 yuan. The constituent stocks are mixed. In terms of rising, Midea Group led the rise, and Changjiang Power followed suit. In terms of decline, China Ping An led the decline, while Contemporary Amperex Technology Co., Limited followed. In the news, Contemporary Amperex Technology Co., Limited, the power battery giant, once again announced that it will build a power battery factory overseas, which will also become the company's third battery factory in Europe. Bank of China Securities said that the important meeting at the end of the year is about to land, and the market may face fluctuations caused by the expected landing of policies in the short term, but the tone of monetary policy will not change. The logic of "wide money+weak credit" will continue in the short term. Under the expectation of loose monetary policy, the upward direction of market volatility will not change. According to industry insiders, looking forward to 2025, the allocation of A-share industry can be developed around three main lines: first, the direction of domestic macro-circulation, attaching importance to "duality and innovation", "debt conversion" and new growth points in the consumption field; Second, science and technology are self-reliant: pay attention to artificial intelligence industry, self-controllable, new energy technology, aerospace information technology and data elements; The third is to open wider to the outside world: pay attention to cross-border e-commerce, digital trade, tax exemption and inbound tourism. You can use the Shanghai and Shenzhen 300ETF South (159925) to lay out the core assets with one click.
Kaidianbao suspended the payment business. On December 11th, Kaidianbao Payment Service Co., Ltd. announced that due to the change of business conditions, in order to protect the interests of merchants and partners to the greatest extent, the company decided to suspend the payment business, and from now on, the existing stock business will be withdrawn and cleaned in an orderly manner, and the businesses with potential risks will be cleaned up before December 20th, 2024. All stock payment services will be suspended after December 31, 2024. Regarding why the business was suspended, the reporter interviewed the legal representative of the company, but did not get a response from the other party. (beijing business today)Shanxi procuratorate decided to arrest Wu Huatai in accordance with the law. The case of former party secretary and chairman of Shanxi Coking Coal Group Co., Ltd. Wu Huatai (director level) suspected of accepting bribes and abuse of power by state-owned company personnel was investigated by Shanxi Provincial Supervision Committee and transferred to the procuratorate for review and prosecution. Under the jurisdiction designated by the Shanxi Provincial People's Procuratorate, the Taiyuan Railway Transportation Branch of the Shanxi Provincial People's Procuratorate reviewed and prosecuted. A few days ago, Taiyuan Railway Transportation Branch of Shanxi Provincial People's Procuratorate made an arrest decision against Wu Huatai on suspicion of accepting bribes and abuse of power by state-owned company personnel. The case is being further processed.On the 11th, soybean oil rose by 1.72%, and the latest main contract positions changed as follows. According to the exchange data, as of December 11th, the main contract soybean oil closed at 2,505, up or down by +1.72%, with a turnover of 529,500 lots. The position data showed that the top 20 seats were clear, and the difference position was 59,880 lots. The total contract turnover of soybean oil futures was 685,800 lots, a decrease of 114,300 lots from the previous day. The first 20 seats in the contract held 687,800 lots, an increase of 15,900 lots over the previous day. The short positions in the top 20 seats of the contract were 775,600 lots, an increase of 3,312 lots over the previous day. (Sina Futures)
On the 11th, the No.20 glue rose by 1.24%, and the latest main contract positions changed as follows. According to the exchange data, as of December 11th, the main contract No.20 glue 2502 closed, up or down by +1.24%, with a turnover of 129,000 lots. The position data showed that the top 20 seats were clear, and the difference position was 7011 lots. A total of 165,900 lots were traded in the No.20 rubber futures contract, a decrease of 59,300 lots from the previous day. The first 20 seats in the contract held 86,900 lots, an increase of 6,181 lots over the previous day. Short positions in the top 20 seats of the contract were 98,100 lots, an increase of 4,267 lots over the previous day. (Sina Futures)Nissan Motor Co., Ltd. reorganized its top management: CFO will be transferred to China to take charge of operations, and Nissan Motor Co., Ltd. is reorganizing its top management, hoping to introduce new talents and reverse the company's declining profits, increasing debts and lack of revenue-generating products. Makoto Uchida will continue to be the CEO of Nissan, while Jeremie Papin will be the CFO at the end of next year, and Christian Meunier will succeed Papin as the chairman of Nissan Americas. In addition, Stephen Ma, the company's chief financial officer, will be transferred to China to take charge of local business operations.On the 11th, the No.20 glue rose by 1.24%, and the latest main contract positions changed as follows. According to the exchange data, as of December 11th, the main contract No.20 glue 2502 closed, up or down by +1.24%, with a turnover of 129,000 lots. The position data showed that the top 20 seats were clear, and the difference position was 7011 lots. A total of 165,900 lots were traded in the No.20 rubber futures contract, a decrease of 59,300 lots from the previous day. The first 20 seats in the contract held 86,900 lots, an increase of 6,181 lots over the previous day. Short positions in the top 20 seats of the contract were 98,100 lots, an increase of 4,267 lots over the previous day. (Sina Futures)
Strategy guide
12-13
Strategy guide 12-13